BLOG

Drug Discovery

Anima Biotech aims to open the ‘black box’ of disease with large-scale cellular experiments

While Anima has contributed to the scientific literature itself, with a growing list of peer-reviewed publications on protein synthesis monitoring and tRNA visualization, Slonim argues that relying solely on mining existing research isn’t enough.